MedTrace Logo

Adherence to Immunosuppressive Therapy Liver Transplant Recipients

NCT01959308 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-10-10

No results posted yet for this study

Summary

Immunosuppressive therapy is fundamental in post-liver transplant patients to prevent and reduce the incidence of acute cellular rejection. Non-compliance to treatment leading to graft rejection is a well-recognized event. This study aims to study the differences in patient compliance to immunosuppressive treatments and patient preference.

Conditions

  • Focus : To Study the Differences in Patient Compliance to Immunosuppressive Treatments and Patient Preference.

Interventions

OTHER

Sponsors & Collaborators

  • National University Hospital, Singapore

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01959308 on ClinicalTrials.gov